Each month, CREATION.co’s respiratory tracking update brings you the latest insights into the online UK healthcare professional (HCP) conversation regarding respiratory disease.
The conversation level of UK HCPs discussing respiratory disease on Twitter
From 21 February to 20 March 2022, the UK HCP respiratory disease online conversation consisted of 2,248 posts. These were authored by 1,147 HCPs, a decrease in both figures from January to February. Once again the mentions of COVID-19 online by UK HCPs diminished, with only 411 total mentions of the pandemic causing illness. Whilst the average number of online posts for UK HCPs discussing respiratory diseases was 1.96, physiotherapist Anne Bruton posted 26 times about the therapy area, making her this month’s most active UK HCP in the respiratory disease online space.
28 February saw the most respiratory disease online posts from UK HCPs this month. A large cause of this was HCPs responding to data analysis findings from the new national charity Asthma and Lung UK, which found that only Turkey has a higher respiratory death rate than the UK, the death rate in Turkey is 162.7 per 100,000 people and 134.5 in the UK. Some shared the sentiment that air pollution is a major contributing factor to these findings, whilst others discussed the impact that images in mainstream media can have on patient education.
The UK has the highest death rate for lung conditions in western Europe, research reveals, prompting calls from health leaders for urgent action to tackle the “national scandal”. https://t.co/22NJJvjOTf @asthmalunguk
— Dr Nick Hopkinson (@COPDdoc) February 28, 2022
HCPs, as well as charities, responded positively to the news of Asthma and Lung UK’s launch, with many pointing to the alarming statistics surrounding lung disease within the UK and the potential beneficial changes the charity could bring about. Awareness of the launch was high amongst UK HCPs who mentioned the charity 99 times on Twitter throughout the month, many of these bringing challenges which the charity can tackle.
BIG NEWS: We’ve become Asthma + Lung UK, the UK charity supporting everyone with a lung condition.
Check out our website to find out about our plans to fight for every breath and watch the video of our story: https://t.co/SuoQTItkB1 #FightingForBreath pic.twitter.com/HHXfiupGN4
— Asthma + Lung UK (@asthmalunguk) February 28, 2022
The most shared post of the month by UK HCPs in the context of respiratory disease, was from chest physician Nawar Bakerly who discussed the negative impacts that Ventolin inhalers have on the environment. This post was shared by over 35 fellow UK HCPs throughout the month and HCPs agreed with the sentiment that green powder inhalers are the future of treatment. HCPs this month also discussed how to choose the optimal inhaler for people with COPD and this focus from HCPs around environmental factors could be an integral part of the future treatment landscape for respiratory disorders.
Not many will know that one Ventolin inhaler emits carbon similar to what an average family car (like a Fiesta) emits driving for 200 miles approximately!! Time to go green with our inhaler prescribing.
— Nawar Bakerly (@NawarBakerly) March 12, 2022
Each month, we track the HCP conversation relating to respiratory disease.
You can keep up to date with this and other pharmaceutical tracking updates, including COVID-19 developments, within the Tracking section of CREATION Knowledge, or sign up to receive our monthly eJournal with all of our latest HCP insights.
If you would like to dig deeper into what we have seen this month then please do get in touch.
- This article analysed the Twitter conversations of HCPs in the UK discussing respiratory disease and related terms between 21 February and 20 March 2022 using CREATION Pinpoint®.
- Between 21 February and 20 March 2022, there were 2,248 UK HCP mentions of respiratory disease and related terms, from 1,147 unique UK HCP authors.